Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

NEW ORLEANS -- A sample of popular over-the-counter supplements had little direct clinical evidence to support their claims, despite citing clinical trials and other research, an evaluative study ...

A handful of states have passed legislation allowing ivermectin to be sold and purchased over-the-counter (OTC) -- and other ...

Combining affordability, sustainability, and smart design, the new private-label line helps meet the growing demand at ...